Chemoinformaics analysis of  Cannabigerolic-Acid
| Molecular Weight | 360.494 | nRot | 10 |
| Heavy Atom Molecular Weight | 328.238 | nRig | 9 |
| Exact Molecular Weight | 360.23 | nRing | 1 |
| Solubility: LogS | -3.095 | nHRing | 0 |
| Solubility: LogP | 7.448 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 61.2854 |
| nHD | 3 | BPOL | 32.9706 |
| QED | 0.366 |
| Synth | 2.796 |
| Natural Product Likeliness | 2.147 |
| NR-PPAR-gamma | 0.945 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.117 |
| Pgp-sub | 0.003 |
| HIA | 0.01 |
| CACO-2 | -5.012 |
| MDCK | 0.0000164 |
| BBB | 0.044 |
| PPB | 0.9871 |
| VDSS | 2.985 |
| FU | 0.0299753 |
| CYP1A2-inh | 0.29 |
| CYP1A2-sub | 0.184 |
| CYP2c19-inh | 0.092 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.712 |
| CYP2c9-sub | 0.483 |
| CYP2d6-inh | 0.833 |
| CYP2d6-sub | 0.128 |
| CYP3a4-inh | 0.068 |
| CYP3a4-sub | 0.029 |
| CL | 3.16 |
| T12 | 0.446 |
| hERG | 0.036 |
| Ames | 0.005 |
| ROA | 0.341 |
| SkinSen | 0.317 |
| Carcinogencity | 0.124 |
| EI | 0.066 |
| Respiratory | 0.81 |
| NR-Aromatase | 0.04 |
| Antiviral | Yes |
| Prediction | 0.736747 |